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Effects of Increase in Amplitude of Occipital Alpha & Theta Brain 
Waves on Global Functioning Level of Patients with GAD
Introduction: The basic objective of this study is to investigate the effects of alpha and theta 
brain waves amplitude increase in occipital area on reducing the severity of symptoms of 
generalized anxiety disorder and to increase the global functioning level in patients with GAD.
Methods: This study is a quasi-experimental study with pre-test and post-test with two groups. 
For this purpose, 28 patients who had been referred to Sohrawardi psychiatric and clinical 
psychology center in Zanjan were studied based on the interview with the psychiatrist, clinical 
psychologist and using clinical diagnostic criteria for the Diagnostic and Statistical Manual of 
Mental Disorders text revision - the DSM-IV-TR Fourth Edition diagnosis of GAD, 14 subjects 
were studied in neurofeedback treatment group and 14 subjects in the waiting list group. Patients 
in both groups were evaluated at pre-test and post-test with General Anxiety Disorder Scale 
(GAD-7) and Global Assessment Functioning Scale (GAFs). The treatment group received 
fifteen 30-minute alpha training sessions and fifteen 30-minute theta brain training sessions 
in occipital area by neurofeedback training (treatment group). This evaluation was performed 
according to the treatment protocol to increase the alpha and theta waves. And no intervention 
was done in the waiting list group. But due to ethical issues after the completion of the study all 
the subjects in the waiting list group were treated.
Results: The results showed that increase of alpha and theta brain waves amplitude in occipital 
area in people with GAD can increase the global functioning level and can reduce symptoms 
of generalized anxiety disorder in a treatment group, but no such change was observed in the 
waiting list group.
Discussion: Increase of alpha and theta brain waves amplitude in occipital area can be useful in 
the treatment of people with GAD.
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1. Introduction
eneralized Anxiety Disorder (GAD) is 
one of the most common psychological 
disorders characterized by excessive and 
uncontrollable worry and it has a high co-
morbidity with other anxiety disorders and 
depression (Barlow, 2002). Fourth Diagnostic and Statisti-
cal Manual of Mental Disorders - Text Revised (DSM-IV-
TR American Psychiatric Association 2000) defines GAD 
as the intense anxiety and worry about several events or ac-
tivities that persists most days during at least 6 months and 
it is difficult to be controlled and in addition, it is alongside 
with physical symptoms such as muscle tension, irritability, 
G
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difficulty sleeping, and restlessness. Annual prevalence of 
GAD has been reported between 3 to 8% and the lifetime 
prevalence rate is approximately 7.5 percent (Kessler and 
Walters and Wittchen, 2004: 29-50). Almost 25 percent of 
people who refer to the anxiety disorders clinics and about 
12% of patients who refer to the psychiatric clinics have 
GAD (Kessler et al., 2004). According to the chronic high 
prevalence and comorbidity of GAD with other psycho-
logical disorders, the disorder has been proposed as one of 
the most disabling disorders for adults (Borkovec, 2006: 
273-287). For this purpose, psychological intervention in 
Generalized Anxiety Disorder has a special place.
Coping strategies which are used in CBT such as treat-
ment homework doing, applied relaxation, cognitive 
structuring, regarded exposure, assertiveness training 
and problem solving can cause self-confidence and en-
hance the patient strategy for coping with harmful effect 
resulting from the disorder. But acquiring coping skills 
calls for attempt, and some of GAD patients may lack 
the necessary motivation for doing this treatment pro-
cess (Kessler et al., 2005). Therefore, Pharmacotherapy 
may be preferred by those patients who are not willing 
to benefit from psychological intervention. Since this 
approach is not dependent much on motivational fac-
tors and because in some cases comorbidity depression 
is viewed as a comorbidity disorder, pharmacotherapy 
along with anti-depressants are considered effective in 
alleviating both anxiety and depression symptom, how-
ever pharmacotherapy cannot make any fundamental 
changes and symptoms recurrent in GAD patients is 
prevalent matter (Tyrer, 1999).
On the other hand, according to the information cur-
rently existing on brain and operating brain capabilities, 
practitioners in various medical situations are increas-
ingly emphasizing on the brain-centered treatment. 
Recent advances imply the understanding of functional 
brain abnormalities in anxiety disorders including gener-
alized anxiety disorder (Nainian et al., 2012). 
Neurofeedback is a comprehensive educational system 
that promotes brain growth and changes at the cellular 
level. Neurofeedback is a form of biofeedback that can 
facilitate localized changes in brain waves, as well as 
changes in local cerebral blood flow (rCBF). This meth-
od enhances connectivity between neurons and increases 
the acceptance of mental flexibility. Each practitioner is 
trained according to the treatment protocol related to his 
disorder and at this stage, improvements are visible for 
the trainee. This method has been successful in treating 
a wide range of disorders such as depression, anxiety, 
post-traumatic stress disorder (PTSD), personality disor-
ders, addictions and emotional problems (Demos, 2005).
Hammond, (2011) studied the literature relating to 
the treatment of anxiety disorders through Neurofeed-
back training. Encouraging preliminary research has 
been published for the effectiveness of neurofeedback 
in treating anxiety with 10 controlled studies that have 
been identified. Out of the eight studies of anxiety that 
were reviewed, seven were found with positive chang-
es. A randomized, blinded, controlled study (Egner & 
Gruzelier, 2003) was done with performance anxiety at 
London’s Royal College of Music. They evaluated the 
ability of alpha-theta neurofeedback to enhance musical 
performance in high-talented musicians when they were 
performing under stressful conditions. When compared 
with alternative treatment groups (physical exercise, 
mental skills training, Alexander Technique training, and 
two other neurofeedback protocols that focused more on 
enhancing concentration), only the alpha- theta neuro-
feedback group resulted in enhancement of real-life mu-
sical performance under stress. Similar randomized con-
trolled studies reducing performance anxiety have been 
conducted with musical performance (Egner & Gru-
zelier, 2003), ballroom dance performance (Raymond, 
Sajid, Parkinson, & Gruzelier, 2005), and performance 
in singing (Kleber, Gruzelier, Bensch, & Birbaumer, 
2008; Leach, Holmes, Hirst, & Gruzelier, 2008). In a 
randomized, placebo-controlled study with medical stu-
dents (Raymond, Varney, Parkinson, & Gruzelier, 2005) 
neurofeedback enhanced mood, confidence, feeling en-
ergetic and composed.
Watson, Woolley-Hart, and Timmons (1979) carried 
out alpha-enhancement in 32 anxious patients using 
eyes-open visual feedback. There were six sessions at 
weekly intervals together with home practice. Because 
this was a pilot study, there were no controls. The au-
thors preferred eyes-open training, so that patients could 
maintain alpha enhancement in the state in which they 
experienced most of their anxiety. Since anxious patients 
do not habituate, and they continue to react to stimuli, 
the visual feedback was not given until the alpha had 
been sustained. More than half of the patients improved 
clinically. Since increased alpha and decreased anxiety 
were correlated, the authors concluded that the outcome 
was more than a placebo effect. Alpha increased before 
anxiety decreased. Patients were not aware of the level 
of alpha success or failure, and they all had a long history 
of anxiety without improvement.
Moor (2005) studied the literature relating to the 
treatment of anxiety disorders through neurofeedback 
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training. Eight studies were done on generalized anxi-
ety disorder, three studies were done on phobia anxiety 
disorder, two studies were done on OCD and one report 
was done on post-traumatic stress disorder. The studies 
by Moor suggested the placebo effect in this study, but 
the increase in alpha and theta training had additional 
effects beyond the placebo and they were considered as 
effective treatments for anxiety disorders.
In order to study the impact of the theta neurofeedback 
training in GAD treatment, Vanathy, Sharma and Kumar 
trained 15 patients (alpha increase and theta increase) 
with GAD diagnostic criteria, after evaluating the base-
line. Post treatment evaluating indicated that alpha and 
theta training caused considerable reduction in personal 
report indices and in ranked anxiety scale. 
Neurofeedback training alters how the brain works, 
and when the skills were trained it appears to have a 
sustained impact. Follow-up studies show long-term 
changes in brain function after the neurofeedback train-
ing. Long-term pharmacotherapy is more costly than the 
neurofeedback training, while there could be less side 
effects for neurofeedback training than the pharmaco-
therapy. 
The present study has been designed in the range of 
the restrictions listed in the field of pharmacotherapy 
and psychological treatments for people with GAD. The 
present study is based on the fact that whether the in-
crease in alpha and theta waves in the occipital region 
could reduce the symptoms of generalized anxiety disor-
der in Iranian samples. 
2. Methods
This study is a quasi-experimental study with pre-
test and post-test with two groups. 28 patients attended 
Suhrawardi psychiatric and clinical psychology institute 
in Zanjan and were randomly assigned to treatment and 
control groups. After informing the patients of the study 
and getting the written consent of the patients, they were 
randomly assigned to one of the groups with regard to 
the inclusion and exclusion criteria. 
Including criteria consisted of: having GAD diagnos-
tic criteria diagnosed by psychiatrist based on diagnostic 
interview and by clinical psychologist based on GAD-7. 
Not being exposed to psychological intervention and no 
use of the drugs by the patient at least one month be-
fore being included in the study. Age between 18-50 and 
being educated at least up to the third grade of junior 
high school. Excluding criteria consisted of having other 
psychological disorder in Axis-I, having serious suicide 
ideation which makes the fixed dose of the drugs im-
possible, and having the complete personality disorder 
criteria in Axis-II diagnosed by psychiatrist based on di-
agnostic interview.
In the treatment group, according to the protocol 
(Moor, 2005) 30 minutes of training alpha waves in-
crease in the occipital area and 30 minutes of training 
theta waves increase in the occipital area (O1 or O2) 
were applied using neurofeedback procomp- 5 device 
and the control group did not receive any intervention. 
According to the international 20-10 system, in order to 
record the activity of alpha and theta waves, an active 
Electroencephalography electrode (EEG) (procomp- 5) 
in the O1 and O2 area and two electrons of reference and 
ground were placed on the right and left ears while the 
patient is sitting in a comfortable chair with eyes wide 
open in front of the screen. Each patient attended 15 neu-
rofeedback sessions training increase in alpha and theta 
brain waves amplitude. All the neurofeedback sessions 
consisted of 5 minutes devoted to attainment of prepa-
ratory relaxation, 2 minutes devoted to recording EEG 
baseline data and 60 minutes devoted to training process. 
Audio reward presentation was contingent on providing 
predetermined criteria which had been explained to the 
patients. The patients were told to try to recognize the 
mental status leading to audio reward. The patients re-
ceived audio feedback in response to the cognitive strat-
egy for enhancing alpha and theta amplitude higher than 
determined thresholds. Then quantitative criteria of the 
alpha and theta wave based on time average and in terms 
of wave amplitude were recorded automatically by the 
neurofeedback device in the scale of microvolt. For col-
lecting data the following instruments were used. A PhD 
clinical psychologist who had been received enough 
training administered the instruments.
2.1. GAFs
GAFs for treatment plan decision and effect has been 
used. Scoring is done based on global functioning level 
ranging from 0-100. The higher score indicate a better 
global functioning (Sadock and Sadock, 2007).
2.2. GAD-7
Due to the defects in existing anxiety measurement 
scales, such as their length and their inefficiency as 
diagnostic scales, GAD questioner has been designed. 
(Spitzer et al., 2005). It consists of 7 items. Each of 
which has score ranging from 0-3. The range of the to-
tal scale is 0-21. (Spitzer et al., 2005) report its internal 
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consistency to be excellent (α=0/92) and its test-retest 
reliability to be good (r=0/83). Sensitivity and specificity 
of the scale in 10 or higher cut off points exceeds 80%. 
GAD-7 scale correlations with subscale SF-20 has been 
reported 39-91% and its correlations with to BAI has 
been reported to be 72% and its correlations with anxiety 
subscale SCL-90 has been reported to be 74%. The GAD 
scales of psychometric properties in the study conducted 
on Iranian populations were studied. Its cronbach’s alpha 
was equal to 85% and the test retest reliability in this 
sample was (r=48%). These values show expectable re-
liability and internal consistency for the scale in Iranian 
sample. By examining its correlations with Spilberger 
state-trait anxiety questionnaires (for state 71%, for trait-
state=52%) and by calculating its correlations with 12 
item anxiety subscales included in clinical symptoms 
check list SCL-90, its concurrent validity has been ob-
tained (r=0/63, P≤0.01.). This value also shows expect-
able validity in Iranian society. 
2.3. Neurofeedback Device
Neurofeedback is a comprehensive health care system 
that works directly with the brain; neurofeedback is de-
vice that breaks the raw signals received from the brain 
into the different frequency waves.
This frequency brain waves is known as delta, theta, 
alpha and beta. During neurofeedback, electrodes were 
placed on the scalp according to the 20-10 internation-
al system. Usually, two electrodes are placed in areas 
where the EEG activity in comparison with the EEG of 
normal people involves higher standard deviation.
The patient is placed in front of the computer and what 
the computer shows can be like a video game - computer 
or display on which a two column chart view shows the 
brain wave activity. This allows the patients to focus 
their attention on the computer screen. When inappro-
priate activity slightly decreased and appropriate activ-
ity increased, a voice was heard. At first the changes in 
brainwaves are transient. But with repeated sessions, and 
with the evolution of the threshold for inhibition of inap-
propriate activities and as the activity of healthy brain 
waves strengthen by the therapist, sustainable changes 
gradually become conditioned (Demos, 2005).
Once the assessment is complete and treatment goals 
have been established, most commonly one or more 
electrodes are placed on the scalp and one or more on the 
earlobes for neurofeedback training sessions (Figure 1). 
The trainee then usually watches a display on the com-
puter screen and listens to audio tones, sometimes while 
doing a task such as reading. These training sessions are 
designed to assist the person to gradually change and 
retrain their brainwave patterns. For example, some per-
sons may need to learn to increase the speed or size of 
brainwaves in specific areas of the brain, whereas other 
individuals need training to decrease the speed of and 
amplitude of their brainwaves. Common initial improve-
ments begin to be noticed within the first 5 to 10 ses-
sions. Length of treatment may only be 15 to 20 sessions 
for anxiety or insomnia, but with other conditions such 
as ADD=ADHD or learning disabilities, it will more of-
ten involve 30 to 50 sessions, depending on the sever-
ity of the problem. Once the equipment is attached each 
session usually lasts about 20 to 25 min. In treating very 
complex conditions or when multiple disorders or diag-
noses are present, a clinician cannot always stipulate in 
advance how many treatment sessions may be required 
(Hammond, 2011).
3. Results 
The Kolmogorov-Smirnov test was used to determine 
the normal distribution of data. Due to the normality of 
data distribution, parametric tests were used to analyze 
the data.
In analyzing the data, descriptive statistics including 
frequency, mean, standard deviation and inferential sta-
tistics, including a set of covariance (ANCOVA) and t-
test for two independent samples were used. 
Table 1 shows Mean, SD independent t-tests on the 
variables of age, education, disease duration, and base-
line variables. Given the lack of significance of differ-
ences in group means, it seems that all three groups were 
homogeneous in these variables before intervention.
After eliminating the grades of the severity of the dis-
order in the pre-test (pre-intervention) which were con-
sidered as covariates, Table 2 shows one-way analysis of 
covariance on the severity of generalized anxiety disor-
der (GAD-7), the Global Assessment Functioning Scale 
(GAFs), and the amplitude of alpha and theta waves in 
the occipital region in the post-test (after intervention). 
The results of this table indicate that they there are statis-
tically significant.
4. Discussion 
The results of the current study show that means of 
alpha and theta brain waves amplitude increased in the 
group who received alpha and theta brain waves ampli-
tude training after fifteen neurofeedback training. The 
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mean amplitude of alpha pre - post test for the neuro-
feedback group were, respectively, 7.32 and 8.97. The 
mean amplitude of theta pre - post test for the neurofeed-
back group were, 7.16 and 7.90, respectively.
The finding also suggests that neurofeedback train-
ing is effective in reducing symptoms of GAD. These 
results are based on the changes in the score of the neu-
rofeedback group in the scale of General Anxiety Disor-
der scale (GAD-7). This procedure can be done in two 
months, with 15 sessions per week on the average 2 to 
3 sessions. Finally it leads to a significant decrease in 
the symptoms of anxiety in patients with generalized 
anxiety disorder. As it was explained in the methodol-
ogy part, the psychiatrist who was double-blinded did 
the diagnostic interview again after the complication of 
the study. The results showed that the treatment group 
patients were not diagnosed with GAD, but the waiting 
list group was diagnosed with GAD and their diagnostic 
symptoms had not been eliminated. But due to ethical is-
sues all the subjects in the waiting list group were treated 
after the completion of the study.
This finding is consistent with some previous studies. 
Watson, Woolley – Timmons and Hart (1979) investigat-
ed increasing alpha in 32 anxious patients with eyes open 
by using visual feedback. In this study, the researchers 
found an increase in alpha brain wave amplitude before 
reducing anxiety. 
Hare and others (1981) treated a group of anxious pa-
tients during six alpha training sessions. These patients 
Figure 1. The stages of neurofeedback training: 1. Measuring brainwaves 2. Extraction of patterns and 
distribution of alpha and theta waves in O1 and O2 3. Transformation of brain waves into feedback 
(eg. game play) 4. Monitoring of feedbacks by subjects. In all stages, neurofeedback device control the 
process of game play transforming brain waves to feedbacks.
t
Waiting list groupNeurofeedback
SDMSDMVariables
1.826.8027.339.9033.67Age
-0.552.8412.423.0411.75Education
0.702.594.254.255.08Illness span
1.252.3713.253.1114.67GAD-7
-1.104.8355.503.1153.67GAFs
0.771.686.831.407.32Alpha Brain Wave Amplitude
-0.801.737.211.097.16Theta Brain Wave Amplitude
Table 1. Mean, Standard Deviation and t-test results in terms of research variables, age variable, educational variables and ill-
ness span variables in pretest (pretreatment). 
*P<0.050. ***P<0.01
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were anxious for 6 years and had not responded to pre-
vious psychotherapy and pharmacotherapy treatments. 
The results showed that alpha brain wave increased in 
the EEG.
Hammond, (2011) studied the literature relating to the 
treatment of anxiety disorders through Neurofeedback 
training. Encouraging preliminary research has been 
published for the effectiveness of neurofeedback in treat-
ing anxiety with 10 controlled studies that have been 
identified. Moore (2005) reviewed the literature related 
to the GAD treatment involving neurofeedback training. 
He mentioned to the increased range of 33 to 88 percent 
for alpha brain wave amplitude in some studies.
Rice, Blanchard and Purcell randomly assigned 38 vol-
unteers fulfilling criteria DSM-III (APA-1980) and the 
other seven subjects who were subclinical and were suf-
fering from two clinical symptoms in five groups each 
with 9 people. The groups where assigned in frontal 
EMG alpha increase feedback, alpha reduction feedback 
or waiting list group. The groups received eight training 
sessions, each lasting 20 minutes.
In order to study the impact of the theta neurofeedback 
training in GAD treatment, Vanathy, Sharma and Kumar 
trained 15 patients (alpha increase and theta increase) 
who had GAD diagnostic criteria after evaluating the 
baseline. Post treatment evaluating indicated that alpha 
and theta training caused considerable reduction in per-
sonal report indices and in ranked anxiety scale. The cur-
rent study suggested that alpha and theta training may 
have appeared in controlling anxiety clinical symptom. 
Birukova (2005) has found similar results as well.
The current study findings seem to confirm the func-
tional changes of brains in alpha waves amplitude. These 
changes can be observed following feedback training 
sessions. It seems that these positive effects and the con-
sistency with the foreign study are the results of common 
aspect of human beings and also the results of the similar 
neurologic conditioning. Although cultural differences 
have not influenced the study results much, the current 
study faced with limitations and the future studies can 
shed more light on the nature of this influence. 
This limitation is related to the subjects who were ran-
domly assigned in two waiting list and experimental 
groups. The inclusion in neurofeedback group has in-
volved some costs and all of the patients have not been 
able to afford it. Although researchers have attempted to 
pay part of the costs, but due to the proliferation of ses-
sions, the problem has not still been resolved.
On one hand, this makes the GAD subjects’ scores from 
the beginning to be different, although the conditions in 
neurofeedback haven’t caused a problem; because this 
group was compared with itself over time, therefore 
the control and experimental groups should be judged 
with caution. Another limitation of the present study was 
respectively the problem of absence of a placebo treat-
ment group (placebo) and absence of the control group 
(intervention group). This problem is due to two things: 
First, the limitations of the sample and second other ethi-
cal concerns.
To sum up the results of the current study, it should be 
mentioned that neurofeedback training in GAD patients 
cause an increase in alpha and theta brain waves am-
plitude and such training is effective in reducing GAD 
symptoms while such changes cannot be observed wait-
ing list group. The results also suggest that on one hand, 
the utilization of neurofeedback training decreased GAD 
patients’ symptoms, while on the other hand it increases 
occupational, social and psychological functioning level 
in GAD patients.
The mind has the power to heal itself, but very often it 
lacks an effective tool to do so. Interventions at different 
and deeper levels are required to produce further change 
and to help the growth. Neurofeedback is one such inter-
vention that is just now coming into its own. In addition, 
Table 2. Mean, Standard Deviation and ANCOVA results in post-test (post treatment).
*P<0.05. ***P<0.01
F
Waiting list groupNeurofeedback
PosttestPretestPosttestPretestVariables
SDMSDMSDMSDM
442.72*2.1013.332.3713.251.553.673.1114.67GAD-7
148.88*4.1255.424.8355.504.1675.923.1153.67GAFs
19.75*1.566.911.686.831.608.971.407.32Alpha Brain Wave Amplitude
6.04*1.627.291.737.211.327.901.097.16Theta Brain Wave Amplitude
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technological advances continue to improve the efficacy 
of neurotherapy (Demose, 2005).
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